InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Peterson Amy C., Vice-Président Exécutif du Développement. Director active across 2 companies, notably CytomX Therapeutics, Inc.. Cumulatively, 10 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €8k. History available since 31 May 2021. The latest transaction was disclosed on 15 May 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Peterson Amy C. is Executive Vice President of Development. She has 10 filings in total, and, across the sampled recent filings from 2021-06-08 to 2025-05-16, buys are 0 EUR and sells are 7960 EUR. The recent filings concern Exelixis, INC. and CytomX Therapeutics, Inc., with notable amounts of 906166.7184514918 EUR on 2024-11-19 and 331224.0641928224 EUR on 2025-05-16 at Exelixis, INC., as well as 16517.40605561804 EUR and 7960.236247579825 EUR at CytomX Therapeutics, Inc.